Hong Kong Stock Movement | Clover Biopharmaceuticals-B (02197.HK) rose over 6% in the afternoon; positive data from Australian Phase II clinical trial of respiratory combination vaccine

Zhito Finance APP has learned that Clover Biopharmaceuticals-B (02197.HK) rose more than 6% in the afternoon. As of press time, it was up 5.24%, at HK$2.01, with a turnover of HK$5.4861 million.